Comparative studies of epibatidine derivatives [18F]NFEP and [18F]N-methyl-NFEP:: Kinetics, nicotine effect, and toxicity

被引:47
作者
Ding, YS [1 ]
Molina, PE
Fowler, JS
Logan, J
Volkow, ND
Kuhar, MJ
Carroll, FI
机构
[1] Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA
[2] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA
[3] Emory Univ, Atlanta, GA 30322 USA
[4] Res Triangle Inst, Res Triangle Pk, NC 27709 USA
关键词
nicotinic acetylcholine receptors; epibatidine; fluorine-18; PET; nicotine; toxicity;
D O I
10.1016/S0969-8051(98)00070-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We have previously shown that [F-18]norchlorofluoroepibatidine ([F-18]NFEP) would be an ideal radiotracer for positron emission tomography (PET) imaging of nicotinic acetylcholine receptors (nAChR); however, its high toxicity is a limiting factor for human studies. We, therefore, synthesized its N-methyl derivative ([F-18]N-Me-NFEP) and carried out comparative studies. The distribution volumes for different brain regions were higher for [F-18]N-Me-NFEP than those for [F-18]NFEP (average: 52.5 +/- 0.9 vs. 36.4 +/- 0.7 for thalamus), though the distribution volume (DV) ratios were similar (3.93 +/- 0.27 vs. 3.65 +/- 0.19 for thalamus to cerebellum). Treatment with nicotine reduced the binding of both radiotracers. Toxicology studies in awake rats showed that N-methyl-NFEP has a lower mortality (0 vs. 30%) and smaller effect on plasma catecholamines than NFEP at a dose of 1.5 mu g/kg, However, marked alterations in cardiorespiratory parameters were observed after injection of N-methyl-NFEP (0.5 mu g/kg, IV) to an awake dog, Our results suggest that although the binding characteristics of [F-18]NFEP and [F-18]N-Me-NFEP appear to be ideally suited for PET imaging studies of the human brain, their relatively small safety margin will limit their use in humans. NUCL MED BIOL 26;1:139-148, 1999. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:139 / 148
页数:10
相关论文
共 40 条
  • [1] ANDERSON DJ, 1995, J PHARMACOL EXP THER, V273, P1434
  • [2] Arneric S. P., 1997, Society for Neuroscience Abstracts, V23, P1199
  • [3] Arneric Stephen P., 1995, P95
  • [4] BADIO B, 1994, MOL PHARMACOL, V45, P563
  • [5] ANTINOCICEPTIVE EFFECTS OF THE ALKALOID EPIBATIDINE - FURTHER-STUDIES ON INVOLVEMENT OF NICOTINIC RECEPTORS
    BADIO, B
    SHI, D
    GARRAFFO, HM
    DALY, JW
    [J]. DRUG DEVELOPMENT RESEARCH, 1995, 36 (01) : 46 - 59
  • [6] Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors
    Bannon, AW
    Decker, MW
    Holladay, MW
    Curzon, P
    Donnelly-Roberts, D
    Puttfarcken, PS
    Bitner, RS
    Diaz, A
    Dickenson, AH
    Porsolt, RD
    Williams, M
    Arneric, SP
    [J]. SCIENCE, 1998, 279 (5347) : 77 - 81
  • [7] BROUSSOLLE EP, 1989, LIFE SCI, V44, P123
  • [8] PHARMACOLOGICAL EFFECTS OF EPIBATIDINE OPTICAL ENANTIOMERS
    DAMAJ, MI
    CREASY, KR
    GROVE, AD
    ROSECRANS, JA
    MARTIN, BR
    [J]. BRAIN RESEARCH, 1994, 664 (1-2) : 34 - 40
  • [9] DEWEY SL, 1992, J NEUROSCI, V12, P3773
  • [10] MAPPING MUSCARINIC RECEPTORS IN HUMAN AND BABOON BRAIN USING [N-C-11-METHYL]-BENZTROPINE
    DEWEY, SL
    MACGREGOR, RR
    BRODIE, JD
    BENDRIEM, B
    KING, PT
    VOLKOW, ND
    SCHLYER, DJ
    FOWLER, JS
    WOLF, AP
    GATLEY, SJ
    HITZEMANN, R
    [J]. SYNAPSE, 1990, 5 (03) : 213 - 223